The present disclosure relates to Raman imaging using surface enhanced Raman spectroscopy substrates.
Surface Enhanced Raman Spectroscopy (“SERS”) is an interesting phenomenon, but it is neither well understood, nor reproducible, nor controllable. Most understanding and SERS work is currently performed on small metal particles to enhance the Raman signal. Currently SERS is applied to enhance the Raman signals of relatively small molecules on surfaces and not large biological entities. Originally SERS was created on electrochemically roughened noble metal surfaces which proved hard to characterize and reproduce. Most of the more recent SERS work involves use of small, 20-200 nm diameter, colloidal particles of Ag or Au due to ease of fabrication and reproducibility. In some cases these particles are treated so that a ligand is attached which acts to bind it to a particular chemical entity. In cases of biological samples, such ligands are referred to as immuno tags which can bind to a well defined protein or receptor in the biological sample. Such tagging is widely used in other medical fields as well but depends on the specific targeted object, thereby preventing this from being a general method to study any material or target entity.
SERS studies have been largely limited by the small size of the SERS probe which has typically been comprised of nano-particles or structures that provide an enhancement at or nearby the structures, typically within nanometers from such structures but as much as five nanometers from the structures. Most SERS and the phenomenology to understand and direct the design of SERS substrates or targets have been based on the desire to maximize the resulting signal from specific molecules not the spatial localization of the enhancement nor the uniformity of the enhancement of the biological objects. Most cases of large SERS require the molecules to be directly bound to the SERS surface thereby allowing new electronic states and optical transitions that lead to strong polarization of the molecule/surface (or particle) complex. It is also known that the local electromagnetic fields are enhanced by small particles or by the creation of localized static fields or “plasmons” in free electron like metals such as Ag or Au, either as small particles, or aggregates of small particles. Designed physical Ag or Au structures such as gratings or arrays are known to couple the incident electromagnetic field to the object to produce resonant field enhancements associated with the plasmons of these structures. These enhanced fields give rise to enhancement of the Raman signal that is combined with any shorter range chemical enhancement. In many cases of small particles, these plasmon fields are very confined and give rise to large SERS enhancements.
The SERS phenomena has been widely studied and has been implemented in numerous ways, for example using Noble metals of Ag and Au in electrochemically roughened surfaces, colloidal particles, sol gels, grating surfaces, microarrays of deposited material, overcoatings on latex spheres and nanofibers, novel material nano-fabrication approaches, lithographically formed nano-arrays and even photonic crystal arrays to name a few. To date, a wide range of results are purported citing various high levels of Raman enhancement of 107 to 1014.
SERS studies of biological entities include the introduction of small nano-particles into cells that may attach to some intracellular biological materials, attachment of colloidal particles to biological objects in solution, disruption of the cell to expose cellular content to the SERS active sites of a substrate or the combined use of antibody-active SERS particles with both antibody and SERS ligands. Such SERS labeled immuno-tagged particles could allow Raman scattering intensities that rival fluorescent tags, with the advantage that Raman would enable many more tags to be detected at one time than possible with fluorescent tags. The drawback of this latter approach for Raman-tagged assays is that immuno-labeling is a reagent based system, i.e., not general, and dependent on having the right immuno-tags and the right chemistry to bond both tag and Raman ligand on the same particle. It is also limited by the need to know the identity of the target material and have an appropriate immunoassay to attach to the target material in the biological object.
The present disclosure provides for a method for imaging biological objects. A SERS surface is provided having a plurality of enhancing structures distributed on the surface wherein the surface includes a two dimensional area of at least 5×105 nm2. A biological material is deposited on the SERS surface. The biological material on the SERS surface is illuminated, via a monochromatic light source, producing Raman scattered photons. The Raman scattered photons are filtered using a two-dimensional tunable filter, in a plurality of predetermined wavelength bands. A two-dimensional array detector detects the filtered Raman scattered photons, in a spatially accurate manner. The results of filtering and detecting steps are combined to produce a plurality of spatially accurate wavelength resolved Raman images of the biological material. In one embodiment, the enhancing structures are uniformly distributed over the surface. In another embodiment, the enhancing structures have a size, in at least one dimension of height, width and length, ranging from 100 nm to 1000 nm.
In one embodiment, the biological material on the SERS surface is illuminated along a first optical path producing Raman scattered photons, along a second optical path, wherein the first optical path is at an oblique angle with respect to the second optical path.
In another embodiment, the steps of illuminating, filtering and detecting are repeated at a plurality of focus depths generating a plurality of outputs. The output is combined to construct a volumetric image of said biological material deposited on the SERS surface.
In yet another embodiment, the SERS surface is supported on a transparent substrate.
The present disclosure further provides for a method for imaging biological objects. A SERS surface is provided having one of the following: a plurality of nanostructures uniformly distributed on the surface and a plurality of mesostructures uniformly distributed on the surface. A biological material is deposited on the SERS surface. A reagent is provided between the biological material and the SERS surface. The biological material on the SERS surface is illuminated, via a monochromatic light source, producing Raman scattered photons. The Raman scattered photons are filtered using a two-dimensional tunable filter, in a plurality of predetermined wavelength bands. A two-dimensional array detector detects the filtered Raman scattered photons, in a spatially accurate manner. The results of filtering and detecting steps are combined to produce a plurality of spatially accurate wavelength resolved Raman images of the biological material.
The present disclosure further provides for a method for imaging objects. A SERS surface is provided having a plurality of enhancing structures distributed on the surface wherein the surface includes a two dimensional area of at least 5×105 nm2. A material is deposited on the SERS surface where the material has at least one dimension of length or width of at least 600 nm. The material on the SERS surface is illuminated, via a monochromatic light source, producing Raman scattered photons. The Raman scattered photons are filtered using a two-dimensional tunable filter, in a plurality of predetermined wavelength bands. A two-dimensional array detector detects the filtered Raman scattered photons, in a spatially accurate manner. The results of filtering and detecting steps are combined to produce a plurality of spatially accurate wavelength resolved Raman images of the material. In one embodiment, the enhancing structures are uniformly distributed over the surface. In another embodiment, the enhancing structures have a size, in at least one dimension of height, width and length, ranging from 100 nm to 1000 nm.
The present disclosure provides for an apparatus used as a diagnostic probe placed on a sample such as tissue, organ or body part. The apparatus includes a monochromatic light source, a plurality of optical fibers, a SERS surfaces, a two dimensional tunable filter, a two dimensional detector and a processor. The optical fibers transmit substantially monochromatic light to a sample and receive Raman scatter photons produced by the sample. The SERS surfaces are located on the exterior of the substrate. The SERS surface has enhancing structures distributed on the surface which includes a two dimensional area of at least 5×105 nm2 and the enhancing structures have a size, in at least one dimension of height, width and length, ranging from 100 nm to 1000 nm. A two dimensional tunable filter filters the Raman scattered photons in a plurality of predetermined wavelength bands. A two dimensional detector detects the filtered Raman scattered photons, in a spatially accurate manner, and generates outputs in response to the Raman scattered photons in a plurality of predetermined wavelength bands. A processor combines the outputs of the two dimensional detector to produce a plurality of spatially accurate wavelength resolved Raman images of the sample.
The accompanying drawings, which are included to provide further understanding of the disclosure and are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and, together with the description, serve to explain the principles of the disclosure.
In the drawings:
Reference will now be made in detail to the embodiments of the present disclosure, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
This disclosure provides for a SERS surface having enhancing structures distributed over the surface wherein the surface includes a two dimensional area of at least 5×105 nm2. In one embodiment the enhancing structures have a size, in at least one dimension of height, width and length, ranging from 100 nm to 1000 nm. The surface is used for the deposition and detection of biological objects having enhanced Raman scattering. The disclosure further provides for methods to produce a plurality of spectrally resolved images and a plurality of spatially resolved spectra, having an enhanced Raman signal, of the biological material deposited on the enhancing structures SERS surface. The uniform SERS surface will enhance the Raman signal 100-1000 times, in a manner which is uniform over an area and extends significantly further away from the surface so as to obtain spatially accurate Raman images of large biological objects. The methods of this disclosure will permit significantly faster spatially resolved Raman imaging from biological objects than previously possible. The imaging will be performed without the need for chemical tagging of the molecular components in the biological object.
In one embodiment, the monochromatic light source 110 is positioned to provide incident light along a first optical path 113, which is at an angle to sample 100, as opposed to light shining orthogonal to sample 100, as illustrated in
The multitude of photons in beam 112 reaching sample 100 illuminate the sample and are scattered from different locations on or within the sample. Scattered photons are schematically represented as beams 116 and 118 while specularly reflected photons are represented schematically as beam 114. The scattered photons are produced along a second optical path 119, wherein the first optical path 113 is at an oblique angle with respect to the second optical path 119.
Referring to
Laser rejection filter 135 may be positioned prior to tunable filter 140 to filter out elastic scattered illumination light represented by beam 116 and to optimize the performance of the system. In other words, rejection filter 135 enables spectral filtering of the photons at the illuminating wavelength.
With further reference to
In another embodiment, the filter may include a two dimensional grating disperser which includes a hologram grating. The hologram grating is fabricated using E-beam fabricated lithography. Grating may be fabricated to achieve spectral wavelength resolution in the visible, UV, infrared or near-infrared wavelength range. The grating is fabricated to achieve spectral resolution over a Raman Shift value in a spectra range of 2800 cm−1 to 3200 cm31 1 corresponding to the carbon-hydrogen stretching modes. In a second embodiment, the grating 108 is fabricated to achieve spectral resolution over a Raman Shift value in the fingerprint region corresponding to a spectra range of 500 cm−1 to 2000 cm−1. Computed Tomography Imaging Spectroscopy (“CTIS”) used as a spectral imaging tool is described in U.S. patent application Ser. No. 11/336,588 entitled “Method for Raman Computer Tomography Imaging Spectroscopy,” which is incorporated herein by reference in its entirety.
A first two-dimensional array of detection elements 145 (“first detector”) detects filtered Raman scattered photons in a spatially accurate manner to generate output to processor 150. The first detector may include a digital device such as an image focal plane array (“FPA”) CCD or CMOS sensor. The optical region employed to characterize the sample of interest governs the choice of the first two-dimensional array detector. For example, a two-dimensional array of silicon charge-coupled device (“CCD”) detection elements can be employed for image analysis with visible wavelength fluorescence and Raman spectroscopy, while gallium arsenide (GaAs) and gallium indium arsenide (GaInAs) FPA detectors can be employed for image analyses at near infrared wavelengths. The choice of such devices depends on the type of sample being analyzed. The first detector 145 detects, in a spatially accurate manner, the scattered photons passed by the tunable filter 140. In one embodiment, each detection element in the first two-dimensional array of detection elements used to form the detection array 145 functions to detect photons scattered from a different spatial location on or within the sample. In one embodiment, the first two-dimensional array of detection elements 145 produces digital images of the entire view of the sample as processed by tunable filter 140.
A second two-dimensional array of detection elements 117 (“second detector”) may include a digital device such as for example CCD or CMOS sensor to detect reflected photons.
It is noted that in both
In each of the embodiments shown in
The output generated by exemplary systems illustrated in
With reference to
In one embodiment, the SERS surface having a plurality of enhancing structures distributed on the surface is envisioned as a porous film showing point to point variations in signal enhancement having standard deviations of only ±15%. This is in contrast to prior art SERS substrates having point to point variations of 200% to 200,000%. In another embodiment, the enhancing structure SERS surface is envisioned as a textured metal film with areas of pores and metal film.
Referring to
In one embodiment, the material includes tissue samples such as thin sections of fresh or paraffin embedded tissue. In another embodiment, the sample includes cellular samples such as those routinely obtained in Fine Needle Aspiration, urine cytology, bronchial lavage, peritoneal lavage, and cervical scraping. In another embodiment, the material has at least one dimension of length or width of at least 600 nm.
In one embodiment, the present disclosure provides for methods to image biological materials positioned laterally across the enhancing structure SERS surface so as to pinpoint the locations of organelles and more accurately detect different biochemicals within the biological material. The higher signal to noise (“S/N”) achieved will enable the detection of more subtle changes in these cellular chemicals that reflect biochemical problems, e.g., cancer or metabolic disorders. In one embodiment, the Raman signals of different biological materials are enhanced without the need for any special immuno tagging agents.
In another embodiment, volumetric imaging with an enhancing structure SERS surface will similarly enable the real space coordinates of these biological maerials and their molecular identity in cells or other biological materials. The volumetric image is obtained by collecting a plurality of spatially resolved Raman spectra and/or a plurality of spectrally resolved Raman images at a plurality of focus depths. The output generated at the plurality of focus depths is then combined to construct a volumetric image of the biological entity. While the natural localization of certain chemicals within the organelles of cells is well known, it is necessary to have the sensitivity and resolution to detect the chemicals. Otherwise harvesting of such material from many cells may be necessary to obtain sufficient material for such an analysis which is problematical if one has only a few cancer cells to work with. Characterization of the distance dependence of the enhancing structures SERS surface will allow recalibration of the actual signal levels, which spatially vary in the z-direction, and reflect the actual relative concentrations of these chemicals throughout the cell.
In yet another embodiment, the present disclosure provides for a surface which is envisioned to have a reservoir of reagent at the SERS surface biological entity interface. This surface will permit a wide range of cell membrane and cellular metabolic studies, including processes and the chemistry of cell membranes. To date this interface and its properties have been very difficult to study due to the extremely thin bilipid layer (˜60 nm) that comprises this membrane as well as the small amount of cellular biochemicals present there. It is further envisioned, that SERS surface structures having both meso-structures, 100 nm to 1000 nm in size in at least one dimension, and nano-structures, 1 nm to 10 nm in size in at least one dimension, for local and extended enhancement can allow the sampling of either or both.
In another embodiment, the present disclosure envisions the discrimination of both local and more distant biological entities using an enhancing structures SERS surface. By varying and selecting the angle of the incident light one can tune the resulting field to probe locally bound structures on the membrane of the biological object or further away from it. This difference in sampling distance essentially exploits the long and short range enhancements that can arise due to different plasmons that can be excited at off normal incidence. Further angular modulation of the incident light can allow comparisons of the two regions and the direct comparison of these different signal contributions thereby allowing each of them to be more clearly delineated. This signal modulation approach is widely known and practices to separate signals, and known as differentiated modulation or “lock-in detection.”
In another embodiment, the present disclosure envisions the fabrication of a device having an enhancing structures SERS surface on a transparent substrate. With reference to
In yet another embodiment, a device is envisioned having a SERS surface on a soft pliable substrate which would allow a disposable sampling head used for handle held units or in particular for disposable probes that could be discarded after use by a patient. The use of this device would allow both a signal enhancement as well as a discardable surface for one time use on patients. For such patient applications it would further be desirable to have an optically transparent protective layer over the outer SERS surface which may come into contact with the patent's biological material. The protective cover would protect the SERS surface from degradation arising in the environment. The protective layer should ideally be thin to minimize separation of the material of interest from the SERS roughness features. Also, the protective layer should have a simple Raman spectrum to avoid confounding the Raman signal from the material of interest.
In another embodiment, it is envisioned that the enhancing structures SERS surface may be used for measurement of Raman optical activity and of weaker Raman features associated with protein chirality. Raman chirality, while having an extremely weak signal, can provide unique and novel information about protein folding. Speeding such measurements up by a thousand fold would enable a measurement that took a week to take 10 minutes. Alternately the ability to produce Raman enhancements over an area could enable measurement of spatially resolved Raman optical activity. This could enable pinpointing locations in a cell where unusual Raman optical activity arises. In addition erroneous protein folding in not only cells but in specific organelles will also be more efficiently detected using such surfaces that allow sub cellular level molecular resolution. These protein-folding problems form the basis of several diseases, such as Alzheimer's and mad cow disease. Due to the need to maintain circular polarization for Raman optical activity, periodic structures will likely inhibit the Raman signal. It is envisioned that random structures will not interfere or significantly reduce measurement of circularly polarized Raman from such surfaces.
In yet another embodiment, reduced laser power, data acquisition time, and/or improved sensitivity is envisioned for Raman spectroscopy based studies of bio-materials due to the enhanced signal levels possible with an enhancing structure SERS surface of the disclosure. In yet another embodiment, reduced laser power or data acquisition time is envisioned for a variety of optical spectroscopy based studies of bio-materials.
With reference to
In one embodiment, the present disclosure uses the system illustrated in
The present disclosure may be embodied in other specific forms without departing from the spirit or essential attributes of the disclosure. Accordingly, reference should be made to the appended claims, rather than the foregoing specification, as indicated in the scope of the disclosure. Although the foregoing description is directed to the preferred embodiments of the disclosure, it is noted that other variations and modification will be apparent to those skilled in the art, and may be made without departing from the spirit or scope of the disclosure.
This application claims the benefit of U.S. Patent Application No. 60/671,397 filed Apr. 14, 2005 entitled “Method and Applications to Enhance and Image Optical Signals from Biological Objects” which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
60671397 | Apr 2005 | US |